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Conclusions: Results obtained with the glass beads agree 
with those obtained from conventional detectors including 
alanine, film and ionisation chambers. This together with the 
waterproof characteristics and minimal fading associated 
with glass bead TLDs confirm their potential as a postal 
dosimetry audit tool. 
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Purpose/Objective: For small radiation fields, the 
uncertainty in dose measurement is higher than for 
conventional radiotherapy fields (Castro 2008). To address 
this, manufacturers have custom designed dosimeters 
specifically for this niche physical treatment condition. 
Several types of small field dosimeters, although convenient, 
still need small field correction factors [SFCF] to achieve a 
valid measure of dose. The aim of this work is to quantify the 
performance of a range of specialized small field dosimeters 
and to show the effect of incorrect application of SFCFs. This 
is done by calculating the result of propagating these errors 
through treatment. 
Materials and Methods: Two sample patient treatments are 
considered: the first case a trigeminal neuralgia and the 
second a brain metastasis. Each patient plan is evaluated 
using the smallest 4mm BrainLAB cone on a Varian Novalis 
linear accelerator. For each case the plan was calculated 
using measured data made with the following small field 
dosimeters: IBA SFD, PTW 60012, PTW microdiamond, 
Australian Air-core dosimeter, Standard Imaging Exradin and 
Gafchromic EBT film. 
Results/ The diodes and the microdiamond were found to 
over-respond. The dose delivered was found to be up to 10% 
less than that prescribed to the target volume, depending on 
the dosimeter used to commission the planning system and 
whether SFCF and volume averaging corrections are applied. 
For small fields, the scintillation dosimeters and film 
required only correction for volume averaging, minimizing 
dosimetric uncertainties. 
Conclusions: A specific patient prescription is tailored to 
account for the individual patient’s needs. However once a 
prescription is made, it should be delivered as accurately as 
possible, irrespective of whether it is a small or large 
treatment field. There is an accepted variability in 
prescriptions for the treatment of brain lesions with small 
fields (e.g. trigeminal neuralgia and brain metastasis), which 
may be attributed in part to the present variability in small 
field dosimetry. Two prescriptions may be delivering the 
same dose, but the dosimetry may be reporting it as 
different. Since clinical response has been used to determine 
the dose prescription protocols, solutions to the challenges of 
small field dosimetry should be agreed upon.  
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Purpose/Objective: To investigate the variability of the 
global gamma index analysis in various commercial 
IMRT/VMAT (Intensity Modulated Radiation Therapy/ 
Volumetric Arc Therapy) Quality Assurance (QA) systems. In 
addition, this study evaluates the relationship of these 
gamma analysis results and clinical dose volume histogram 
(DVH) for VMAT treatment plans and to understand how 
systematic VMAT multileaf collimator (MLC) positional errors 
affect the patient dose distribution. 
Materials and Methods: Five commercial QA systems (IBA 
MatriXX, SunNuclear ArcCHECK, PTW 2D-Array, Varian EPID, 
and Gafchromic EBT2 film) were used for defining the global 
gamma index variability in IMRT /VMAT plans and two of QA 
systems (IBA MatriXX and SunNuclear ArcCHECK) and their 
commercial QA system software (IBA-COMPASS and 
ArcCHECK- 3DVH) were used to evaluate the relationship of 
these gamma analysis results and DVH in VMAT plans. Five 
prostate plans (two IMRT and three VMAT) and five larenks 
plans (two IMRT and three VMAT ) were modified by the 
introduction of systematic MLC errors and were evaluated in 
each sytem. Systematic MLC errors were simulated for error 
magnitudes of 0.25, 0.5, 1, 2 and 5 mm. The two types of 
systematic MLC errors were: (1) MLC banks are shifted in the 
same direction (left or right) and (2) MLC banks are shifted in 
opposing directions resulting in smaller or larger field shapes. 
Error-induced plans were measured on a linear accelerator 
and were evaluated against the error-free dose distribution 
calculated using Varian Eclipse treatment planning system in 
the relevant phantom CT scan. A theoretical gamma analysis 
was calculated in each commercial QA system software (IBA 
OmniPro, SNC Patient, PTW Verisoft,Varian Portal Dosimetry 
and IBA OmniPro, respectively) using treatment planning 
system. For evaluating the relationship of the gamma analysis 
and DVH, all QA verification plans were delivered and 
estimated 3D patient dose on the 3DVH and COMPASS 
software. QA gamma analysis of 3%/3 mm and 2%/2 mm were 
implemented and relationships to dose differences in DVH 
metrics encountered due to MLC errors were determined. 
Results: The 2 mm systematic errors were difficult to detect 
using 3%/3 mm but were detectable for criteria of 2%/2 mm. 
This study has shown that various commercial software agree 
well with each other in calculating the predicted global 
gamma index passing at even tight passing criteria of 2%/2 
mm. There is lack of consistently strong correlation between 
gamma indexes and clinical DVH metrics for PTV and OARs. 
Conclusions: There was considerable variation in the type of 
errors that the various systems detected. It was also found 
that the calibration and measuring procedure could benefit 
from improvements for some of the patient QA. 
    
 
 
 
 
 
